Glenmark Pharmaceuticals gets FDA nod for Baddi plant in HP

Glenmark Pharmaceuticals on Monday said it has received the US Food and Drug Administration's approval for its semi solid dosage manufacturing plant at Baddi in HP.

MUMBAI: Glenmark Pharmaceuticals on Monday said it has received the US Food and Drug Administration's approval for its semi solid dosage manufacturing plant at Baddi in HP.

The Baddi plant has also received GMP approval from the UK nodal agency Modern Humanities Research Association and from therapeutic products directorate, Canada. Glenmark informed the BSE.
READ MORE
ADVERTISEMENT

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Industry › Healthcare/Biotech › Pharmaceuticals › Glenmark Pharmaceuticals gets FDA nod for Baddi plant in HP
Text Size:AAA
Success
This article has been saved

*

+